Sign in
Subscribe
News
Tech trail
Trade floor
Export
The Killer50
Oxford
Blogs
Awards
Directory
Events
A worldwide window to Cambridge business, innovation and technology
Cambridge companies could do with more ambition, says UK tech gospeller Eben Upton
Eben Upton, CEO at Cambridge microcomputer innovator Raspberry Pi, has urged other tech companies in the Cluster to show more ambition in their global growth strategies.
UK and India boost trade by billions via historic deal
The UK and India have today agreed a landmark trade deal. Indian tariffs will be slashed, locking in reductions on 90 per cent of tariff lines, with 85 per cent of these becoming fully tariff-free within a decade.
40 years of the ARM chip: From Cambridge to the world
As tech entrepreneur and Acorn Computers co-founder Hermann Hauser recently reminded me, the ARM chip which made its bow 40 years ago this month was actually christened the Acorn RISC Machine considering where it was founded.
Cambridge duo Mosaic and Astex agree cancer collaboration
Mosaic Therapeutics, a Cambridge-based targeted oncology therapeutics company resolving cancer’s complexity with new combination therapies, has in-licensed two clinical-stage oncology programs from Astex Pharmaceuticals.
Nyobolt recharges its cash batteries with $180m boost and targets $multibillion markets
Nyobolt, a Cambridge-based pioneer of high-power ultrafast charging technologies has secured $150 million in contracts plus $30m in investment from international backers.
Academia
Sharewatch
Manufacturing
IfM Cambridge helps steer electric shipping initiative
05 May 2025 - 12:00
World-first trial indicates immunosuppression may help treat Parkinson’s disease
09 Apr 2025 - 12:00
Magnificent seven funded in Quadram-NNUH healthcare venture
28 Mar 2025 - 12:00
Business awards
Entries now being accepted
Business directory
Browse our listings of Cambridge companies
The killer 50
The 50 hottest disruptive technology companies
News
Arm makes history by smashing more records in blockbusting Q4
Cambridge superchip architect Arm notched record-breaking results in Q4, capping what CEO Rene Haas called ‘another great year.’
Cambridge companies could do with more ambition, says UK tech gospeller Eben Upton
Eben Upton, CEO at Cambridge microcomputer innovator Raspberry Pi, has urged other tech companies in the Cluster to show more ambition in their global growth strategies.
1Spatial riding a see-saw macro economy
Cambridge location software specialist 1Spatial reports further progress in the year to January 31 with more contracts on the way.
Qualified attorney is new Domainex CEO
Domainex, a multi-award-winning, integrated drug discovery contract research organisation based in Cambridge, has unveiled Hayley French as its new Chief Executive Officer.
More news
Tech trail
AI with the human touch
Genie AI is a very different kind of artificial intelligence company. And co-founder Rafie Faruq is a very different type of hot gospeller in the field.
Mode in the millions to progress chemical sensing innovation
Oxford University spin-out Mode Labs has secured £3 million investment to transform chemical sensing.
SpeechTech entrepreneur Steve Young takes chair at Inephany
Cambridge dontrepreneur Professor Steve Young, who has sold tech companies to Microsoft, Google and Apple over the course of his academic career, has become an angel investor in and chair of London-based AI startup Inephany.
Nyobolt recharges its cash batteries with $180m boost and targets $multibillion markets
Nyobolt, a Cambridge-based pioneer of high-power ultrafast charging technologies has secured $150 million in contracts plus $30m in investment from international backers.
More Tech trail
Trade floor
Alchemab could net $415m from Eli Lilly deal
Alchemab Therapeutics, whose labs are in Cambridge UK, stands to scoop up to $415 million from Eli Lilly and Company following a landmark first deal of its kind for the startup.
Rein Therapeutics and Qureight broaden life science collaboration
A collaboration between Nasdaq quoted biopharma company Rein Therapeutics in Texas and Cambridge UK innovator Qureight Ltd could hold huge potential for the treatment of idiopathic pulmonary fibrosis (IPF).
CN Bio partners with Pharmaron to expand organ-on-a-chip capabilities
Cambridge-based organ-on-a-chip (OOC) innovator CN Bio has unveiled a strategic partnership with global R&D service provider Pharmaron. Under the agreement, Pharmaron will validate CN Bio’s PhysioMimix® technology across existing applications and collaborate on integrating OOC technologies into its R&D platform.
Cambridge duo Mosaic and Astex agree cancer collaboration
Mosaic Therapeutics, a Cambridge-based targeted oncology therapeutics company resolving cancer’s complexity with new combination therapies, has in-licensed two clinical-stage oncology programs from Astex Pharmaceuticals.
Boehringer Ingelheim and Tessellate Bio tackle hard-to-treat cancers in €500m deal
Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have struck a research collaboration and global licence agreement to develop first-in-class, oral precision treatments for people living with cancer.
More Trade floor
